Association between erythropoietin gene polymorphisms and diabetic retinopathy

Archives of Ophthalmology

Volumn 128, Issue 1, 2010, Pages 102-106

  Abhary, Sotoodeh ^a   Burdon, Kathryn P ^a   Casson, Robert J ^c   Goggin, Michael ^b,d   Petrovsky, Nikolai P ^a   Craig, Jamie E ^a  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ERYTHROPOIETIN; INSULIN; CHOLESTEROL; CREATININE; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; DNA EXTRACTION; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLYCEMIC CONTROL; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETINA MACULA EDEMA; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; BLOOD PRESSURE; BODY MASS; CLINICAL TRIAL; GENETICS; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR;

ADULT; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ERYTHROPOIETIN; FEMALE; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 75349097521     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.355     Document Type: Article

References (34)

1. Kempen JH, O'Colmain BJ, Leske MC, et al; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552-563.
2. Wang GL, Semenza GL. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A. 1993;90(9):4304-4308.
3. Yamaji R, Okada T, Moriya M, et al. Brain capillary endothelial cells express two forms of erythropoietin receptor mRNA. Eur J Biochem. 1996;239(2):494-500.
4. Anagnostou A, Lee ES, Kessimian N, Levinson R, Steiner M. Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells. Proc Natl Acad Sci U S A. 1990;87(15):5978-5982.
5. Hernández C, Fonollosa A, Garcia-Ramirez M, et al. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care. 2006;29(9):2028-2033.
6. García-Ramírez M, Hernandez C, Simo R. Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. Diabetes Care. 2008;31(6):1189-1194.
7. Anagnostou A, Liu Z, Steiner M, et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci U S A. 1994;91(9):3974-3978.
8. Grimm C, Wenzel A, Acar N, Keller S, Seeliger M, Gassmann M. Hypoxic preconditioning and erythropoietin protect retinal neurons from degeneration. Adv Exp Med Biol. 2006;588:119-131.
9. Katsura Y, Okano T, Matsuno K, et al. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care. 2005; 28(9):2252-2254.
10. Watanabe D, Suzuma K, Matsui S, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med. 2005;353(8):782-792.
11. Takagi H, Watanabe D, Suzuma K, et al. Novel role of erythropoietin in proliferative diabetic retinopathy. Diabetes Res Clin Pract. 2007;77(suppl 1):S62-S64.
12. Tong Z, Yang Z, Patel S, et al; Genetics of Diabetes and Diabetic Complication Study Group. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A. 2008;105(19):6998-7003.
13. Chen J, Connor KM, Aderman CM, Willett KL, Aspegren OP, Smith LE. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci. 2009;50(3):1329-1335.
14. Inomata Y, Hirata A, Takahashi E, Kawaji T, Fukushima M, Tanihara H. Elevated erythropoietin in vitreous with ischemic retinal diseases. Neuroreport. 2004; 15(5):877-879.
15. Online Mendelian Inheritance in Man Web site. http://www.ncbi.nlm.nih. gov/sites /entrez. Accessed January 2009.
16. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98(5)(suppl):786-806.
17. Solé X, Guino E, Valls J, Iniesta R, Moreno V. SNPStats: a web tool for the analysis of association studies. Bioinformatics. 2006;22(15):1928-1929.
18. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70(2):425-434.
19. Hallman DM, Huber JC Jr, Gonzalez VH, Klein BE, Klein R, Hanis CL. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care. 2005;28(5):1163-1168.
20. Arar NH, Freedman BI, Adler SG, et al; Family Investigation of Nephropathy and Diabetes Research Group. Heritability of the severity of diabetic retinopathy: the FIND-Eye study. Invest Ophthalmol Vis Sci. 2008;49(9):3839-3845.
21. Monti MC, Lonsdale JT, Montomoli C, Montross R, Schlag E, Greenberg DA. Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes. J Clin Endocrinol Metab. 2007;92(12):4650-4655.
22. Hietala K, Forsblom C, Summanen P, Groop PH; FinnDiane Study Group. Heritability of proliferative diabetic retinopathy. Diabetes. 2008;57(8):2176-2180.
23. Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabet Med. 2002;19(11): 910-916.
24. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC; Pima Diabetes Genes Group. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Diabetes. 1998;47(5):821-830.
25. Looker HC, Nelson RG, Chew E, et al. Genome-wide linkage analyses to identify loci for diabetic retinopathy. Diabetes. 2007;56(4):1160-1166.
26. Rogus JJ, Poznik GD, Pezzolesi MG, et al. High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach. Diabetes. 2008; 57(9):2519-2526.
27. Osterholm AM, He B, Pitkaniemi J, et al. Genome-wide scan for type 1 diabetic nephropathy in the Finnish population reveals suggestive linkage to a single locus on chromosome 3q. Kidney Int. 2007;71(2):140-145.
28. Chistiakov DA, Savost'anov KV, Shestakova MV, et al. Confirmation of a susceptibility locus for diabetic nephropathyonchromosome3q23-q24 by association study in Russian type 1 diabetic patients. Diabetes Res Clin Pract. 2004;66(1):79-86.
29. Imperatore G, Knowler WC, Nelson RG, Hanson RL. Genetics of diabetic nephropathy in the Pima Indians. Curr Diab Rep. 2001;1(3):275-281.
30. Placha G, Canani LH, Warram JH, Krolewski AS. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis. 2005;12(2):155-169.
31. Iyengar SK, Abboud HE, Goddard KA, et al; Family Investigation of Nephropathy and Diabetes Research Group. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the Family Investigation of Nephropathy and Diabetes (FIND). Diabetes. 2007;56(6):1577-1585.
32. Li Y, Nowotny P, Holmans P, et al. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc Natl Acad Sci U S A. 2004;101(44):15688-15693.
33. Lin PI, Martin ER, Bronson PG, et al. Exploring the association of glyceraldehyde-3-phosphate dehydrogenase gene and Alzheimer disease. Neurology. 2006; 67(1):64-68.
34. Lin PI, Vance JM, Pericak-Vance MA, Martin ER. No gene is an island: the flipflop phenomenon. Am J Hum Genet. 2007;80(3):531-538.